Literature DB >> 18273737

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.

Michael Soyka1, Henry R Kranzler, Mats Berglund, David Gorelick, Victor Hesselbrock, Bankole A Johnson, Hans-Jürgen Möller.   

Abstract

These practice guidelines for the biological treatment of substance use disorders were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal during the development of these guidelines was to review systematically all available evidence pertaining to the treatment of substance use disorders, and to reach a consensus on a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence. These guidelines are intended for use by physicians evaluating and treating people with substance use disorders and are primarily concerned with the biological treatment of adults suffering from substance use disorders. The data used to develop these guidelines were extracted primarily from various national treatment guidelines for substance use disorders, as well as from meta-analyses, reviews and randomized clinical trials on the efficacy of pharmacological and other biological treatment interventions identified by a search of the MEDLINE database and Cochrane Library. The identified literature was evaluated with respect to the strength of evidence for its efficacy and then categorized into four levels of evidence (A-D). This first part of the guidelines covers the treatment of alcohol dependence; Part 2 will be devoted to the treatment of drug dependence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18273737     DOI: 10.1080/15622970801896390

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  14 in total

1.  Training in Substance-Related and Addictive Disorders, Part 1: Overview of Clinical Practice and General Recommendations.

Authors:  Gilles Fleury; Robert Milin; David Crockford; Leslie Buckley; Dara Charney; Tony P George; Nady el-Guebaly
Journal:  Can J Psychiatry       Date:  2015-12       Impact factor: 4.356

Review 2.  [Nalmefene: a novel pharmacotherapeutic option for alcoholism].

Authors:  M Soyka
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

3.  Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder.

Authors:  Andrew Naglich; Bryon Adinoff; E Sherwood Brown
Journal:  CNS Drugs       Date:  2017-08       Impact factor: 5.749

Review 4.  Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.

Authors:  Elizabeth M Oliva; Natalya C Maisel; Adam J Gordon; Alex H S Harris
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

Review 5.  The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the treatment of adolescent sexual offenders with paraphilic disorders.

Authors:  Florence Thibaut; John M W Bradford; Peer Briken; Flora De La Barra; Frank Häßler; Paul Cosyns
Journal:  World J Biol Psychiatry       Date:  2015-11-23       Impact factor: 4.132

Review 6.  Buprenorphine use in pregnant opioid users: a critical review.

Authors:  Michael Soyka
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

7.  [Treatment outcome after inpatient alcohol withdrawal: impact of motivational interventions: a comparative study].

Authors:  S Loeber; F Kiefer; F Wagner; K Mann; B Croissant
Journal:  Nervenarzt       Date:  2009-09       Impact factor: 1.214

8.  Training and fidelity monitoring of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia: the IMPACT Effectiveness Trial.

Authors:  Hilary Connery; Shelly Greenfield; Viktoriya Livchits; Lana McGrady; Nickolette Patrick; Charmaine S Lastimoso; Jessica H Heney; Adrianne Katrina Nelson; Alan Shields; Yekaterina P Stepanova; Lidia Y Petrova; Oleg V Anastasov; Olga I Novoseltseva; Sonya S Shin
Journal:  Subst Use Misuse       Date:  2013-06-10       Impact factor: 2.164

Review 9.  Alcohol-induced psychotic disorder: a review.

Authors:  Gerhard P Jordaan; Robin Emsley
Journal:  Metab Brain Dis       Date:  2013-12-05       Impact factor: 3.584

Review 10.  Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.

Authors:  Berend Malchow; Alkomiet Hasan; Paolo Fusar-Poli; Andrea Schmitt; Peter Falkai; Thomas Wobrock
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-08-21       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.